YouTube Censors Judicial Watch Video on
Election Integrity and Biden Corruption --Locks Watchdog Out of Account for
Seven Days
You, dear supporter, and Judicial Watch have again been victimized by Big
Tech censorship.
YouTube censored our video
about Biden corruption and election integrity issues in the 2020 election.
The video, titled “Impeach? Biden Corruption Threatens National
Security,” was falsely determined to be “election misinformation” and
removed by YouTube, and our YouTube account was suspended for a week.
(Judicial Watch continues to post its
video content on its Rumble channel (https://rumble.com/vz7aof-fitton-impeach-biden-corruption-threatens-national-security.html).)
We are America’s largest nonpartisan government watchdog group, and the
latest YouTube attack limited our ability to share our educational videos
and other educational content with nearly half-million YouTube
subscribers.
Judicial Watch is also the nation’s leading election integrity
organization, and we have testified
to Congress on the issue. Most recently we filed a lawsuit that stopped
an extreme gerrymander by Democrats in Maryland. We also successfully
pursued federal litigation in multiple states to clean up millions of dirty
names from voter registration lists.
YouTube previously deleted a Judicial Watch video
at the request of California government officials, according to
documents we uncovered last year. I was also banned
by the Chinese communist-controlled Tik-Tok earlier this year. (Our friends
at the Heritage Foundation were also censored by YouTube this week.)
YouTube censored
us to help advance a partisan and leftist agenda on election and other
issues. Just in time for another election season, Big Tech, with the direct
encouragement of President Joe Biden, is escalating the corrupt ‘Great
Suppression’ of conservative and government critics online. Elon Musk’s
commitment to free speech is welcome, but Big Tech remains an enemy of the
First Amendment.
Judicial Watch Book A Republic Under Assault Goes on Sale
in Paperback on May 17
Our New York Times bestseller book, A Republic Under Assault,
The Left’s Ongoing Attack on American Freedom, will be available for
sale in paperback on May 17. The paperback edition features a new
introduction that takes on the current DC corruption crisis:
Here is the truth: The Biden administration is corrupt but weak. His party
barely controls Congress. President Biden has a personal corruption
problem, has obvious health challenges, must manage internal warfare
between his party’s corrupt corporate wing and its rising Communists, and
his moral claim on the presidency is rejected by a massive number of
voters.
This is our third New York Times bestselling book. The first two,
The
Corruption Chronicles and Clean
House, revealed what Judicial Watch uncovered in our battles
against Obama secrecy. A Republic Under Assault is a hard-hitting,
fast-paced look at how the Radical Left and the Deep State tried to destroy
the Trump presidency.
The Left spent years targeting President Donald J. Trump--but anyone who
believes in the U.S. Constitution, believes the United States must have
clearly defined and protected borders, believes in the need for a strong
military, believes in the value of hard work and faith, and believes in the
rule of law and American exceptionalism could be next.
This book reveals many secrets that the government and corrupt media tried
to cover up. Readers will learn how the Left continues to assault our
Republic on every front – from undermining election integrity, to illegal
spying on Americans, to suppressing free speech, to destroying our borders
and the rule of law.”
A Republic Under Assault debuted at #14 on the New York
Times’s combined print and eBook list and spent two consecutive
weeks on the NYT’s Hardcover Nonfiction list. The book also
spent three consecutive weeks in the top three of Publishers
Weekly’s Hardcover Nonfiction list and two weeks in the top five of
USA Today’s list. Additionally, the book spent three consecutive
weeks in the top three of the Wall Street Journal’s combine
print/eBook nonfiction list and three consecutive weeks in the top three of
the WSJ’s hardcover nonfiction list.
Sean Hannity, #1 New York Times bestselling author of Live
Free or Die, said this: “When it comes to fighting for the American
people’s ‘right to know,’ no one holds a candle to Tom Fitton and his
team at Judicial Watch. A Republic Under Assault lays bare the
condemning facts Judicial Watch continues to expose about ‘Obamagate,’
the Deep State’s seditious coup to bring down Donald Trump, and much
more. This is must-reading for every American who wants to save our
nation.”
Texas Researcher Warned Wuhan Lab of COVID Investigation by
Congress
In a major development, Judicial Watch obtained 412
pages of records revealing that Dr.
James W. Le Duc, then-director of the Galveston National Laboratory at
the University of Texas Medical Branch (UTMB), warned Chinese researchers
at the Wuhan Institute of Virology of potential investigations into the
covid issue by Congress. These startling documents show that China had
partners here in the United States willing to go to bat for them on the
Wuhan lab controversy.
The documents show Le Duc praising the Wuhan researchers and Chinese
officials for their transparency and handling of the COVID-19 outbreak,
and, in April 2021, Le Duc accepting a request to be on the Biosafety
Advisory Committee of Westlake University in Hangzhou, China. The Galveston
National Laboratory is one of the largest active biocontainment
facilities on a U.S. academic campus.
We received the records in response to our January 20, 2020, Texas Public
Information Act (PIA) request to the University of Texas Medical Branch
that asked for:
All emails, email chains, text messages,
email attachments, calendar invitations, and calendar invitation
attachments by James W. LeDuc, Director, Galveston National Laboratory,
University of Texas Medical Branch, to and from domains ending in nih.gov
or .cn (the Peoples Republic of China Government Domain) containing any of
the following terms and parameters:
- Wuhan within 10 words of coronavirus OR covid* OR
SARS-CoV-2;
- Wuhan within 10 words of mcl OR lab* OR institute;
- Wuhan within 10 words of virology OR virus OR disease*;
- Wuhan within 10 words of biocontainment;
- Wuhan within 10 words of safety OR scien* OR breach;
- Peter within 10 words of Daszak.
The records include an email
dated April 16, 2020, with the subject line “Rubio” from David Franz,
former Commander of the U.S. Army Medical Research Institute of Infectious
Diseases, who informs Le Duc, “I heard from someone in government this
evening that Senator Rubio is starting to push for an investigation
regarding Wuhan lab. Just found it on the web at Forbes by Kenneth Repoza.
Title of article is ‘eight senators call for investigation into
coronavirus origins.’” (https://www.forbes.com/sites/kenrapoza/2020/04/16/eight-senators-call-for-investigation-into-coronavirus-origins/?sh=1ac354835049)
Le Duc then forwards the email to Dr.
Shi Zhengli, a top Chinese virologist known for her work with
coronavirus at the Wuhan Institute of Virology, requesting a phone
conversation “soon” about the email.
On April 18, 2020, Zhengli rejects Dr. De Luc’s request: “Due to the
complicated situation, I don't think it's a right time to communicate by
the call. What I can tell you is that this virus is not a leaky [sic] from
our lab or any other labs. It's a shame to make this scientific question so
complicated.”
Le Duc responds:
I understand completely and I certainly do not wish to compromise you
personally or your research activities. Given our long history of
collaborations between the GNL Galveston National Laboratory and the WIV
(Wuhan Institute of Virology), I have been approached repeatedly for
details on our work. Attached is a draft summary that I will be providing
to the leadership of our University of Texas system and likely to
Congressional committees that are being formed now
The draft attachment was not included in the documents we received.
In an email
dated April 20, 2020, Le Duc informs Zhengli and the Director of the Wuhan
National Biosafety Laboratory at the Chinese Academy of Sciences, Dr.
Yuan Zhiming, that he is concerned that the Wuhan lab would continue to
be the focus of investigation:
I’m afraid that this discussion will continue for some time regarding
where early coronavirus work was being done, the role, if any, of the Wuhan
CDC in research on bat-associated coronaviruses, and exactly when
scientists at WIV [Wuhan Institute of Virology] first became aware of the
new coronavirus and had possession of specimens in the WIV and where was
that work done (level of biocontainment).
A February 9, 2020, email
from Le Duc prepares Zhiming with questions that may arise in an
investigation of the origins of the COVID-19 virus. Le Duc warns that
questions about the virus originating from the Wuhan Institute of Virology
initially came only from social media, but had recently expanded to
“alternate information sources,” “senior officials” and
“reputable newspapers” all linking the opening of the ABSL 4 facility
at the as the source of the virus outbreak.
I just think that we need to aggressively address these rumors and
presumably false accusations quickly and provide definitive, honest
information to counter misinformation. If there are weaknesses in your
program, now is the time to admit them and get them corrected.
I trust that you will take my suggestions in the spirit of one friend
trying to help another during a very difficult time.
Questions Le Duc attached for Zhiming to help prepare include:
Where is coronavirus research
conducted?
- What level of biocontainment?
- How many different laboratories actually
handle live virus?
- Where are coronavirus stocks
stored?
- Is there an inventory record of each
isolate of each coronavirus kept? If so, are there any discrepancies
between the record and actual current inventory number (i.e., is there
evidence to suggest that virus stocks may have been stolen or used without
proper record?)
Virus Stocks
- What are the coronaviruses in your possession that are most closely
related to nCoV [novel coronaviruses] based on genetic sequences and are
able to replicate in culture?
- Is anyone on your team conducting gain of function studies,
recombination studies or any other studies that may have resulted in the
creation of the nCoV?
Personnel
- How many people have access to the coronavirus stocks and
laboratory?
- Senior investigators? Junior investigators? Technical support staff?
Post-docs? Students? Animal handlers? Janitors and other cleaning staff?
Building support personnel? Others?Does the Institute have an occupational
health clinic where employees and students can go to seek medical care? If
so, was there any indication of unusual illness similar to that seen for
nCoV among Institute staff?
- Does a serum bank exist for staff and students working on infectious
agents? If yes, could a current serum and the most recent banked sera be
serologically tested for antibody to nCoV in an effort to document
seroconversion?
Geography
- Where and when were the first Wuhan (or Hubei Province) residents
infected with the nCoV first identified (hospital or clinic name/date of
earliest cases)?
- Do staff members of the Institute reside in the district serviced by
this (these) hospital/clinic(s)?
- Do staff members of the Wuhan Institute of Virology frequent the sea
food/live market first associated with the nCoV outbreak?
- Did any staff member visit the market in the weeks prior to it being
closed? If so, how many staff frequent the market? How often would they
visit the market during the period of interest?
In an April 26, 2021, email
Ting Yuan from the Center
for Infectious Disease Research at Westlake University in China writes
to Le Duc regarding an official appointment as “a member of Biosafety
Advisory Committee” and asks for his input “while we are building our
BSL-3 labs.” Later that day, Le Duc accepts the offer.
In an email
dated May 6, 2019, Le Duc thanks Gale Bernabe, National Institutes of
Allergy and Infectious Diseases (NIAID) regional program officer for Global
Research for East/South Asia and Pacific, for taking his call to discuss
“possible funding sources for collaborative work with China.”
Le Duc informs Bernabe about a proposal to begin work in Wuhan later in the
year.
We have already submitted a proposal and if successful we would begin work
in Wuhan later this year. My goal is to Identify a similar funding
mechanism that would allow the US side partners to receive similar support
for these collaborations. Our vision is that the work will be conducted in
true collaboration with some undertaken in the US and some in Wuhan by
investigators that are in frequent contact and visiting each other
frequently
Le Duc attaches two documents titled: “Wuhan National Biosafety
Laboratory, Chinese Academy of Sciences Advanced Customer Cultivation
Project Call Announcement” and “Wuhan National Biosafety Laboratory,
Chinese Academy of Sciences Advanced Customer Cultivation Project
Application Form.”
On November 25, 2019, Le Duc emails
Zhiming, commenting on a draft manuscript titled, “China's First
Biosafety Level 4 (BSL-4) Laboratory for Fighting Infectious
Disease.”
Le Duc informs Zhiming that his paper was “nicely written” concerning
biocontainment labs in China, however, the paper should be expanded “to
let readers know that security is an important aspect of your
program.”
In an email
dated January 16, 2020, Le Duc congratulates Dr.
George F. Gao, director-general of the Chinese Center for Disease
Control and Prevention (China CDC), on his leadership and China’s
response to COVID-19. Le Duc includes two articles of interest and further
states:
As you might expect, we are following the evolving story on nCoV from Wuhan
very closely and we are eager to get an isolate for antiviral testing. Dr
Tseng's [ https://microbiology.utmb.edu/faculty/chien-te-(kent)-tseng-phd]
lab here in the GNL [Galveston National Laboratory] has developed a
transgenic mouse model for SARS that is very useful and we are anxious to
see if it can be used for the nCoV [novel coronavirus] as well.
- Benjamin Rusek, National Academy of Sciences
- Dave Franz, Commander of the U.S. Army Medical Research Institute of
Infectious Diseases (Retired)
- Dr. Yuan Zhiming
- Dr. George F. Gao
- Mifang F Liang, Chinese Center for Disease Control and
Prevention
- Dr. Pei-Yong Shi, Associate Chief Research Officer, Galveston National
Laboratory, UTMB
In an email
dated March 20, 2020, Le Duc thanks Zhiming for his “heroic efforts to
control the epidemic in Wuhan. Your success is an inspiration to all of us
as we work to halt transmission here in the USA and in other
countries.”
Le Duc informs Zhiming that the U.S. was at the start of the “explosion
of cases in our region and over the next few weeks we would see very high
numbers of cases requiring hospitalizations and ICU support,” and
suggests that “it would be excellent if we could identify areas for
collaborations.”
In an April 29, 2020, email,
NIAID Associate Director for International Research Affairs Gray Handley
informs Le Duc of an inquiry from U.S. Embassy in Beijing, “asking what
was the official name of your DoD supported training program and some other
background information. ... Also, can you assure these responses to their
questions are accurate?”
To the question: “Did this training take place in the U.S., China, or in
both countries?” Handley writes that since 2013 the Galveston National
Laboratory was “part of the NIH Biodefense Laboratory Network [and]
provided laboratory safety and security training for high-level
biocontainment facilities in China, including the Wuhan Institute of
Virology.”
To the question: “Is this relationship still ongoing?” Handley writes:
“This relationship has been facilitated since 2015 through an ongoing
dialogue and regular collaboration meetings cosponsored by the Chinese
Academies of Science and the U.S. National Academies of Science,
Engineering and Medicine with cooperation from the Chinese CDC and
others.”
Le Duc responds to Handley: “The title for both projects was National
Biocontainment Training Center.
The Center was supported by two separate awards: W81XWH-09-2-0053 covering
the period [May 22, 2009, to December 21, 2014], and W81XWH-11-2-0148
covering the period [July 2011 to July 2016].”
In an email
dated February 20, 2021, Zhiming responds to a “Happy New Year” note
from Le Duc:
During the last year, we all experienced the hardest time, fighting against
the virus, fighting against the rumors. The lab operated smoothly [and]
efficiently, providing a crucial platform for pathogen identification,
animal modeling, antiviral drug screening and vaccine development, and we
are very proud of the role and achievements of the laboratory. Here, I
would like to express my sincere thanks to you and your colleagues for your
assistance for the safety and secure operation of the lab.
I really hope you could come back here after
the epidemic, and we could share our understanding on lab management and
infectious disease control.
Previously, through FOIA requests and lawsuits, we have uncovered a
substantial amount of information surrounding COVID-19, including
communications of Anthony Fauci and other U.S. officials, as well as
biosafety issues here in the United States. Our findings include:
- April 2022: Records from the Federal Select Agent Program (FSAP)
reveal safety
lapses and violations at U.S. biosafety laboratories that conduct
research on dangerous agents and toxins.
- May 2022: HHS records regarding biodistribution studies and related
data for the COVID-19 vaccines show a key component of the vaccines
developed by Pfizer/BioNTech, lipid nanoparticles (LNPs), were found outside
the injection site, mainly the liver, adrenal glands, spleen and
ovaries of test animals, eight to 48 hours after injection.
- March 2022: HHS records include emails
between National Institutes of Health (NIH) then-Director Francis
Collins and Anthony Fauci, the director of National Institute of
Allergy and Infectious Diseases (NIAID), about hydroxychloroquine and
COVID-19.
- March 2022: HHS records show the State Department and NIAID knew
immediately in January 2020 that China
was withholding COVID data, which was hindering risk assessment and
response by public health officials.
- December 2021: HHS records include a grant application for research
involving the coronavirus that appears to describe “gain
of function” research involving RNA extractions from bats,
experiments on viruses, attempts to develop a chimeric virus and efforts to
genetically manipulate the full-length bat SARSr-CoV WIV1 strain molecular
clone.
- August 2021: HHS records include an “urgent
for Dr. Fauci” email chain, citing ties between the Wuhan lab and the
taxpayer-funded EcoHealth
Alliance. The government emails also report that the foundation of U.S.
billionaire Bill Gates worked closely with the Chinese government to pave
the way for Chinese-produced medications to be sold outside China and help
“raise China’s voice of governance by placing representatives from
China on important international counsels as high-level commitment from
China.”
- July 2021: NIAID records reveal that it gave
nine China-related grants to EcoHealth Alliance to research coronavirus
emergence in bats and was the NIH’s top issuer of grants to the Wuhan lab
itself. The records also include an email from the vice director of the
Wuhan Lab asking an NIH official for help finding disinfectants for
decontamination of airtight suits and indoor surfaces.
- June 2021: HHS records reveal that from 2014 to 2019, $826,277
was given to the Wuhan Institute of Virology for bat coronavirus research
by the NIAID.
- March 2021: HHS records show that NIH officials tailored
confidentiality forms to China’s terms and that the World Health
Organization (WHO) conducted an unreleased, “strictly confidential”
COVID-19 epidemiological analysis in January 2020.
- October 2020: Fauci emails
include his approval of a press release supportive of China’s response to
the 2019 novel coronavirus.
Until next week,
|
